Place · Level 3
Iron
两种形式 · 红血球的核心 · 储存有名片 · 不该乱补
Last updated
Story path
- 1Two kinds of ironTwo kinds of iron
- 2Gut · gated by needGut · gated by need
- 3Heme biosynthesis · 8 stepsHeme biosynthesis · 8 steps
- 4Red cells · oxygen courierRed cells · oxygen courier
- 5Ferritin · the storage name tagFerritin · the storage name tag
- 6Deficiency ≠ anemia (yet)Deficiency ≠ anemia (yet)
- 7Don't supplement blindlyDon't supplement blindly
Chapter 1
Two kinds of iron
Two kinds of iron
Dietary iron comes in two forms; chemical state decides its absorption fate.
Heme iron is Fe²⁺ wrapped in a porphyrin ring, sourced from animal hemoglobin and myoglobin (meat, liver, blood, fish). Absorption 15–35%, stable, barely affected by other foods at the same meal. It enters enterocytes directly through HCP1 (heme carrier protein), then HO-1 (heme oxygenase) releases the iron from the porphyrin ring inside the cell.
Non-heme iron is free Fe³⁺/Fe²⁺ from plants (legumes, leafy greens, fortified grains, nuts) plus egg yolk and a few animal sources. Absorption 2–20%, highly variable, dominated by what else is on the plate. It must first be reduced to Fe²⁺, then transported into the enterocyte via DMT1.
Non-heme absorption swings several-fold because the iron has to survive the gut lumen before DMT1 can take it. Acidic reducers — vitamin C, citric acid, lactic acid — reduce Fe³⁺ back to Fe²⁺ and chelate it, escorting it to the door; tannins in tea and coffee, phytate in whole grains and raw legumes, and oxalate in spinach bind iron first into insoluble complexes, locking it up before it ever reaches that door; calcium and milk are the strongest same-meal suppressors of non-heme iron. Heme iron sits out this contest — the whole porphyrin ring goes through a different door (HCP1), which is why its absorption rate is stable.
The full enhancer/inhibitor list, and how to arrange meals around it, live on this scene's meal-table quick reference page.
RDA: men 8, women 18, pregnancy 27 mg/day — women need more than double men, mostly because of menstrual loss.
Heme iron is Fe²⁺ wrapped in a porphyrin ring, sourced from animal hemoglobin and myoglobin (meat, liver, blood, fish). Absorption 15–35%, stable, barely affected by other foods at the same meal. It enters enterocytes directly through HCP1 (heme carrier protein), then HO-1 (heme oxygenase) releases the iron from the porphyrin ring inside the cell.
Non-heme iron is free Fe³⁺/Fe²⁺ from plants (legumes, leafy greens, fortified grains, nuts) plus egg yolk and a few animal sources. Absorption 2–20%, highly variable, dominated by what else is on the plate. It must first be reduced to Fe²⁺, then transported into the enterocyte via DMT1.
Non-heme absorption swings several-fold because the iron has to survive the gut lumen before DMT1 can take it. Acidic reducers — vitamin C, citric acid, lactic acid — reduce Fe³⁺ back to Fe²⁺ and chelate it, escorting it to the door; tannins in tea and coffee, phytate in whole grains and raw legumes, and oxalate in spinach bind iron first into insoluble complexes, locking it up before it ever reaches that door; calcium and milk are the strongest same-meal suppressors of non-heme iron. Heme iron sits out this contest — the whole porphyrin ring goes through a different door (HCP1), which is why its absorption rate is stable.
The full enhancer/inhibitor list, and how to arrange meals around it, live on this scene's meal-table quick reference page.
RDA: men 8, women 18, pregnancy 27 mg/day — women need more than double men, mostly because of menstrual loss.
Iron supplements in practice
When dietary iron isn't enough and ferritin is already low, supplements are a useful tool — but picking the wrong form or wrong timing wastes most of the dose.Main forms:
| Form | Elemental Fe | Absorption | Side effects |
|---|---|---|---|
| Ferrous sulfate | 20% (~65 mg/tablet) | Standard, cheap | GI upset most common |
| Ferrous fumarate | 33% | Similar to sulfate | Similar |
| Ferrous gluconate | 12% | Slightly gentler | Less GI upset |
| Bisglycinate | 20% | Better, gentler | Pricier, good for sensitive gut |
| Polysaccharide-iron complex | 100% (labeled) | Inferior to ionic | Virtually no GI upset |
| Ferric carboxymaltose (IV) | n/a | ~100% | Rapid correction, medical setting |
Dose principle (2020s refresh): the old idea of 'split into 2–3 doses/day (60 mg × 2–3)' has been overturned. Moretti 2015 and Stoffel 2017 show that alternate-day single doses of 60–120 mg work better — each iron pulse raises hepcidin for ~24 hours and suppresses the dose that follows it. In Stoffel 2017, cumulative fractional absorption was ~21.8% with alternate-day dosing versus ~16.3% with consecutive-day dosing. So 'every-other-day fasting pill + 250 mg vitamin C' delivers more absorbed iron than 'three times a day with meals'.
Key points: avoid tea, coffee, milk, and calcium supplements at the same meal; treat deficiency for at least 3–6 months until ferritin climbs back to ~50 µg/L before stopping.
For GI intolerance, switch to gluconate or bisglycinate, move to every-other-day, or take with food (absorption drops ~30% but adherence improves).
moretti-2015-blood-iron-hepcidinstoffel-2017-lancet-haematol-iron
Meal-table quick reference
A lookup page — the mechanism lives in the scene body.| Enhancers (Fe³⁺ → Fe²⁺ reduction + chelation) | Inhibitors (lock-up / competition) |
|---|---|
| Vitamin C ~25 mg, doubles absorption | Tea/coffee tannins, ~60% inhibition |
| Meat/fish at same meal (heme synergy) | Phytate (raw legumes, whole grains) |
| Citric/lactic acid (fermented foods) | Oxalate (spinach) |
| Mild acid (lemon water, vinegar) | Calcium/milk (strong non-heme block) |
Practical: vegetarians should pair every meal's plant iron with vitamin C, and push tea/coffee an hour after meals.
Chapter 2
Gut · gated by need
Gut · gated by need
Unlike most nutrients, iron absorption is reverse-regulated — the body has no active iron excretion route, so it controls total iron by controlling uptake.
The regulatory core is hepcidin (a 25-amino-acid peptide secreted by the liver). The mechanism:
1. Ferroportin (FPN) on the enterocyte basolateral membrane is the only exit channel from cell into blood
2. Hepcidin binds ferroportin, internalizes and degrades it, closing the channel
3. Iron piled up inside enterocytes leaves with normal epithelial shedding into stool — net absorption drops
Hepcidin itself responds to several signals: iron stores full (high ferritin) → hepcidin up → door shut; stores low → hepcidin down → door open; hypoxia or high erythropoietic demand → erythroferrone lowers hepcidin → door open; inflammation (interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation.) → hepcidin spikes sharply, iron locked inside macrophages and enterocytes — this is the chemical root of anemia of chronic disease.
So healthy people don't overload — hepcidin throttles automatically. Hereditary hemochromatosis (HFE mutation) breaks hepcidin response, causing lifelong over-absorption with iron accumulating in liver, heart, and pancreas. Chronic inflammation (IBD, RA, CKD) sustains high hepcidin so that even with low stores, iron can't enter — refractory anemia.
A counter-intuitive but elegant system — the body decides whether to absorb iron, not you.
The regulatory core is hepcidin (a 25-amino-acid peptide secreted by the liver). The mechanism:
1. Ferroportin (FPN) on the enterocyte basolateral membrane is the only exit channel from cell into blood
2. Hepcidin binds ferroportin, internalizes and degrades it, closing the channel
3. Iron piled up inside enterocytes leaves with normal epithelial shedding into stool — net absorption drops
Hepcidin itself responds to several signals: iron stores full (high ferritin) → hepcidin up → door shut; stores low → hepcidin down → door open; hypoxia or high erythropoietic demand → erythroferrone lowers hepcidin → door open; inflammation (interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation.) → hepcidin spikes sharply, iron locked inside macrophages and enterocytes — this is the chemical root of anemia of chronic disease.
So healthy people don't overload — hepcidin throttles automatically. Hereditary hemochromatosis (HFE mutation) breaks hepcidin response, causing lifelong over-absorption with iron accumulating in liver, heart, and pancreas. Chronic inflammation (IBD, RA, CKD) sustains high hepcidin so that even with low stores, iron can't enter — refractory anemia.
A counter-intuitive but elegant system — the body decides whether to absorb iron, not you.
Anemia of chronic disease vs IDA
Anemia of chronic disease (ACD) is a common clinical diagnostic trap.Mechanism: chronic inflammation (RA, IBD, CKD, cancer, chronic infection) raises interleukin-6: A pro-inflammatory signal molecule (cytokine) released by immune cells during inflammation., which strongly upregulates hepcidin and locks iron inside macrophages and enterocytes — plasma iron is low, red cells can't be made, but iron stores are normal or elevated.
Differentiating true deficiency from ACD:
Iron deficiency anemia (IDA): ferritin drops (<30), transferrin saturation drops, plasma iron dropsACD: ferritin normal or elevated (acts as an inflammation marker), transferrin saturation drops, plasma iron dropsSoluble transferrin receptor (sTfR) is the gold-standard discriminator: elevated in IDA, normal in ACD
Treatment is opposite: IDA gets iron supplements; ACD requires treating the underlying disease first (plain iron supplementation is ineffective and can worsen inflammation and oxidative stress).
Practical: any anemia should start with ferritin + C-reactive protein: A liver protein that rises with inflammation — a common blood marker for 'is the body inflamed'./ESR — high ferritin plus high CRP suggests ACD; low ferritin suggests true deficiency.
Chapter 3
Heme biosynthesis · 8 steps
Heme biosynthesis · 8 steps
Loading iron into hemoglobin isn't a single step — it's an 8-step assembly line spanning mitochondria and cytosol. Any block stalls red cell production.
Step 1 (mitochondria, rate-limiting): glycine + succinyl-CoA → δ-aminolevulinic acid (ALA). The rate-limiting enzyme is ALA synthase (ALA-S), the master switch for the whole pathway, negatively regulated by heme (high heme shuts it down). Cofactor: vitamin B6 (PLP). This is why B6 deficiency produces microcytic hypochromic anemia (looks like iron deficiency but the block is synthesis), and why anti-TB drug isoniazid (INH), which antagonizes B6, does the same.
Step 2 (cytosol): 2× ALA → porphobilinogen (PBG), via ALA dehydratase (ALA-D), a zinc enzyme. This is lead's first target — lead displaces Zn²⁺, ALA piles up in blood and urine.
Steps 3–6 (cytosol): 4× PBG → hydroxymethylbilane (HMB) → uroporphyrinogen III → coproporphyrinogen III, closing the porphyrin ring and finishing side-chain modifications.
Steps 7–8 (back into mitochondria): coproporphyrinogen III → protoporphyrinogen IX → protoporphyrin IX (oxidative finish). The final step is ferrochelatase, which inserts Fe²⁺ into the porphyrin ring — heme is complete. This is lead's second target — lead takes the Fe²⁺ seat, Fe²⁺ can't enter, Zn²⁺ substitutes, erythrocyte zinc-protoporphyrin (ZPP) rises. ZPP reflects average exposure over the past few months and is run alongside blood lead in occupational medical surveillance; the decisive test for lead exposure is the blood lead level — ZPP is insensitive to recent or acute exposure.
Iron's upstream supply depends on copper as a hidden cofactor. Ceruloplasmin and hephaestin are multicopper oxidases that convert Fe²⁺ to Fe³⁺ so iron can load onto transferrin and be exported. Copper deficiency paralyzes iron mobilization — even with full iron stores, heme can't be made. This is 'copper anemia', often misdiagnosed as IDA.
On throughput: marrow makes ~2 million red cells per second, needing ~20 mg new iron per day for new heme (95% from recycled old red cells; net absorption is only 1–2 mg).
Lead poisoning is a double hit: ALA-D inhibited (blood and urine ALA rise) and ferrochelatase inhibited (ZPP rises). If you see 'anemia + sufficient iron + sufficient B6', check for lead. Chronic low-dose childhood lead exposure permanently damages cognition — after the US began phasing lead out of gasoline in 1973 (the full ban on road-vehicle leaded fuel came only in 1996) and banned lead paint in 1978, mean childhood blood lead dropped from 15 µg/dL to <1, and mean IQ rose 2–5 points.
Step 1 (mitochondria, rate-limiting): glycine + succinyl-CoA → δ-aminolevulinic acid (ALA). The rate-limiting enzyme is ALA synthase (ALA-S), the master switch for the whole pathway, negatively regulated by heme (high heme shuts it down). Cofactor: vitamin B6 (PLP). This is why B6 deficiency produces microcytic hypochromic anemia (looks like iron deficiency but the block is synthesis), and why anti-TB drug isoniazid (INH), which antagonizes B6, does the same.
Step 2 (cytosol): 2× ALA → porphobilinogen (PBG), via ALA dehydratase (ALA-D), a zinc enzyme. This is lead's first target — lead displaces Zn²⁺, ALA piles up in blood and urine.
Steps 3–6 (cytosol): 4× PBG → hydroxymethylbilane (HMB) → uroporphyrinogen III → coproporphyrinogen III, closing the porphyrin ring and finishing side-chain modifications.
Steps 7–8 (back into mitochondria): coproporphyrinogen III → protoporphyrinogen IX → protoporphyrin IX (oxidative finish). The final step is ferrochelatase, which inserts Fe²⁺ into the porphyrin ring — heme is complete. This is lead's second target — lead takes the Fe²⁺ seat, Fe²⁺ can't enter, Zn²⁺ substitutes, erythrocyte zinc-protoporphyrin (ZPP) rises. ZPP reflects average exposure over the past few months and is run alongside blood lead in occupational medical surveillance; the decisive test for lead exposure is the blood lead level — ZPP is insensitive to recent or acute exposure.
Iron's upstream supply depends on copper as a hidden cofactor. Ceruloplasmin and hephaestin are multicopper oxidases that convert Fe²⁺ to Fe³⁺ so iron can load onto transferrin and be exported. Copper deficiency paralyzes iron mobilization — even with full iron stores, heme can't be made. This is 'copper anemia', often misdiagnosed as IDA.
On throughput: marrow makes ~2 million red cells per second, needing ~20 mg new iron per day for new heme (95% from recycled old red cells; net absorption is only 1–2 mg).
Lead poisoning is a double hit: ALA-D inhibited (blood and urine ALA rise) and ferrochelatase inhibited (ZPP rises). If you see 'anemia + sufficient iron + sufficient B6', check for lead. Chronic low-dose childhood lead exposure permanently damages cognition — after the US began phasing lead out of gasoline in 1973 (the full ban on road-vehicle leaded fuel came only in 1996) and banned lead paint in 1978, mean childhood blood lead dropped from 15 µg/dL to <1, and mean IQ rose 2–5 points.
Porphyria: rare but dramatic
Porphyrias are metabolic diseases caused by genetic defects in any of the heme synthesis enzymes — 8 steps means at least 7 subtypes, with vastly different clinical pictures.Acute intermittent porphyria (AIP, the classic): partial PBG deaminase deficiency. Under stress (drugs, fasting, hormones), ALA and PBG accumulate in the liver, producing severe abdominal pain plus neuropsychiatric symptoms (hallucinations, anxiety, seizures). King George III's 'madness' is suspected to be AIP attacks.
Porphyria cutanea tarda (PCT): uroporphyrinogen decarboxylase deficiency. Porphyrins deposit in skin; sun exposure produces blisters, skin fragility, and hypertrichosis.
Erythropoietic protoporphyria (EPP): ferrochelatase deficiency. Red cells accumulate protoporphyrin; bright light produces burning skin pain (but no blisters).
Legend vs reality: medieval werewolf myths (nocturnal, photophobic, abnormal hair, receding gums exposing teeth) have long been speculatively linked to porphyrias — weak evidence but dramatic. AIP prevalence is ~1/20,000 in European descent; other subtypes are rarer.
The reason to teach porphyrias is that they are the perfect reverse-tutorial of the heme synthesis pathway — seeing what each step actually does through gene knockouts is the gold standard of mechanism learning.
puy-2010-lancet
机制 · 完整反应链与铜的隐形辅助
血红素合成完整走一遍, 会看到八步分工清楚, 每一步都在把上一步的产物往下传。第 1 步在线粒体里: 甘氨酸和琥珀酰-CoA 拼成 δ-氨基乙酰丙酸 (ALA), 这一步的酶叫 ALA 合酶, 是整条通路的总开关 —— heme 自己多了就会反过来关掉它 (负反馈), 而这个酶工作需要维生素 B6 (PLP) 当帮手。这就是为什么 B6 缺乏也会出现小细胞低色素性贫血, 看着像缺铁, 实则是合成卡壳; 抗结核药异烟肼 (INH) 会拮抗 B6, 也是同一个机制。
第 3–6 步都发生在胞质里: 4 个 PBG 分子头尾相连, 先合成羟甲基胆烷 (HMB), 再变成尿卟啉原 III、粪卟啉原 III —— 卟啉环在这几步里闭合, 侧链也修饰完成。
第 7–8 步产物被送回线粒体收尾: 粪卟啉原 III 变成原卟啉原 IX, 再氧化成原卟啉 IX。最后铁螯合酶把铁嵌进这个环里, heme 才算做成 (见本幕正文)。
铁能顺利走到这一步, 离不开铜在上游打下手。铜蓝蛋白 (ceruloplasmin) 和 hephaestin 是两种含铜的酶, 负责把 Fe²⁺ 氧化成 Fe³⁺, 铁只有变成 Fe³⁺ 才能挂上转铁蛋白被运出细胞。缺铜会让这一步瘫痪 —— 即使体内储铁充足, 也合成不出 heme, 这种情况叫铜性贫血, 临床上很容易被误诊成缺铁。
产能上, 骨髓每秒造约 200 万个红血球, 每天需要约 20 mg 新铁装进新 heme, 其中约 95% 来自老红血球回收, 净吸收只需要 1–2 mg。
铅卡住的那两步, 在化验单上各留下一道痕迹: 第 2 步被卡住时, ALA 在血里和尿里堆积; 最后一步被卡住时, 锌顶替了铁进到卟啉环里, 红血球里的锌原卟啉 (ZPP) 因此升高。ZPP 反映的是过去几个月的累积暴露, 在职业健康监护里是和血铅一起做的补充指标; 真正判定铅暴露的决定性检查是血铅浓度, ZPP 对近期或急性暴露不敏感。而第 1 步的酶缺了 B6 也会停工, 所以光是 B6 不够, 也会造出一份看起来跟缺铁一模一样的贫血。
童年铅暴露的代价是永久性的。慢性低剂量铅暴露会伤害认知, 美国 1973 年起分阶段削减汽油含铅量 (道路车辆用含铅汽油到 1996 年才全面禁止)、1978 年禁用含铅涂料后, 儿童平均血铅从 15 µg/dL 跌到 < 1 µg/dL, 平均 IQ 随之上升约 2–5 分 —— 这也是为什么铅暴露筛查值得当作常规检查, 而不是等到出问题才想起来查。
Chapter 4
Red cells · oxygen courier
Red cells · oxygen courier
Heme is already built (previous scene). Now, once loaded into hemoglobin (Hb), the protein geometry decides how it loads O₂ in the lung and unloads in tissue. This is a triumph of protein engineering, not a chemical reaction.
Tetramer geometry: Hb is an α₂β₂ tetramer — 2 α and 2 β chains, each cradling one heme and one Fe²⁺. One Hb has 4 oxygen binding sites; each Fe²⁺ reversibly binds 1 O₂. Only Fe²⁺ (ferrous) can carry oxygen — oxidation to Fe³⁺ produces methemoglobin, which cannot (caused by nitrites, benzocaine, aniline toxicity).
R/T allostery and cooperativity: the T (tense) state at low O₂ keeps subunits pulled tight, low O₂ affinity; the R (relaxed) state at high O₂ loosens subunits, high O₂ affinity. The first O₂ binds with difficulty; each subsequent O₂ binds more easily — this is cooperativity. The result is an S-shaped (sigmoidal) oxygen dissociation curve — near-100% saturated in the lung (PO₂ 100 mmHg), rapidly unloading in tissue (40 mmHg).
Bohr effect (Christian Bohr, 1904): tissue metabolism produces CO₂, H⁺, and heat — the curve shifts right, so Hb releases more O₂ at the same PO₂; in the lung CO₂ is exhaled, pH rises, the curve shifts left, more O₂ loads. One molecule, two environments, auto-tuned — an evolutionary marvel.
2,3-BPG (bisphosphoglycerate), a byproduct of red cell glycolysis, stabilizes the T state and shifts the curve right (easier unloading). High altitude or chronic hypoxia raises 2,3-BPG within hours as adaptation; stored blood loses 2,3-BPG, so newly transfused blood actually delivers oxygen poorly for several hours.
Fetal hemoglobin (HbF, α₂γ₂): γ chains bind 2,3-BPG poorly, so HbF's curve is left-shifted with higher affinity than maternal HbA — the fetus can outcompete the mother for oxygen at the placenta. HbF is progressively replaced by HbA in the first 6 months of life.
Geometric-defect diseases:
Sickle cell (HbS): β chain position 6 Glu → Val. On deoxygenation, Hb polymerizes into long fibers; red cells twist into sickles, blocking microvasculature and hemolyzing.β-thalassemia: insufficient β chain production; excess α precipitates, red cells are destroyed by the spleen before maturing — microcytic hypochromic anemia plus marrow hyperplasia.α-thalassemia: insufficient α chain; severity graded by how many α genes are missing (loss of all 4 is fatal in utero).
Production and recycling: marrow makes ~2 million red cells per second, ~200 billion per day; lifespan 120 days; recycled by spleen and liver macrophages; 95% of the iron is reused, only 1–2 mg lost per day.
Hemoglobin isn't just a 'container for iron' — it's a breathing molecular machine, where a single amino-acid mutation can collapse the entire oxygen transport system.
Tetramer geometry: Hb is an α₂β₂ tetramer — 2 α and 2 β chains, each cradling one heme and one Fe²⁺. One Hb has 4 oxygen binding sites; each Fe²⁺ reversibly binds 1 O₂. Only Fe²⁺ (ferrous) can carry oxygen — oxidation to Fe³⁺ produces methemoglobin, which cannot (caused by nitrites, benzocaine, aniline toxicity).
R/T allostery and cooperativity: the T (tense) state at low O₂ keeps subunits pulled tight, low O₂ affinity; the R (relaxed) state at high O₂ loosens subunits, high O₂ affinity. The first O₂ binds with difficulty; each subsequent O₂ binds more easily — this is cooperativity. The result is an S-shaped (sigmoidal) oxygen dissociation curve — near-100% saturated in the lung (PO₂ 100 mmHg), rapidly unloading in tissue (40 mmHg).
Bohr effect (Christian Bohr, 1904): tissue metabolism produces CO₂, H⁺, and heat — the curve shifts right, so Hb releases more O₂ at the same PO₂; in the lung CO₂ is exhaled, pH rises, the curve shifts left, more O₂ loads. One molecule, two environments, auto-tuned — an evolutionary marvel.
2,3-BPG (bisphosphoglycerate), a byproduct of red cell glycolysis, stabilizes the T state and shifts the curve right (easier unloading). High altitude or chronic hypoxia raises 2,3-BPG within hours as adaptation; stored blood loses 2,3-BPG, so newly transfused blood actually delivers oxygen poorly for several hours.
Fetal hemoglobin (HbF, α₂γ₂): γ chains bind 2,3-BPG poorly, so HbF's curve is left-shifted with higher affinity than maternal HbA — the fetus can outcompete the mother for oxygen at the placenta. HbF is progressively replaced by HbA in the first 6 months of life.
Geometric-defect diseases:
Sickle cell (HbS): β chain position 6 Glu → Val. On deoxygenation, Hb polymerizes into long fibers; red cells twist into sickles, blocking microvasculature and hemolyzing.β-thalassemia: insufficient β chain production; excess α precipitates, red cells are destroyed by the spleen before maturing — microcytic hypochromic anemia plus marrow hyperplasia.α-thalassemia: insufficient α chain; severity graded by how many α genes are missing (loss of all 4 is fatal in utero).
Production and recycling: marrow makes ~2 million red cells per second, ~200 billion per day; lifespan 120 days; recycled by spleen and liver macrophages; 95% of the iron is reused, only 1–2 mg lost per day.
Hemoglobin isn't just a 'container for iron' — it's a breathing molecular machine, where a single amino-acid mutation can collapse the entire oxygen transport system.
Anemia is not one disease
'Anemia' is hemoglobin below the lower reference limit — but anemia is a symptom, not a diagnosis. You need to classify before you can treat.By red cell size (MCV):
Microcytic hypochromic (MCV <80 fL): common causes — iron deficiency, anemia of chronic disease, β-thalassemia. Iron deficiency drops ferritin, transferrin saturation, and serum iron; ACD has normal-or-high ferritin (hepcidin locks iron away) but low serum iron. Iron supplementation works opposite ways here — deficiency needs iron; chronic disease needs the primary disease treated first.
Macrocytic (MCV >100 fL): common causes — B12 or folate deficiency, also called megaloblastic anemia. DNA synthesis stalls, red cells grow large but few, with hypersegmented neutrophils. B12 deficiency elevates both homocysteine and methylmalonic acid; folate deficiency elevates only homocysteine. Folate alone cannot repair B12's neural damage (see folate/B12 story).
Normocytic normochromic (MCV 80–100): common causes — acute blood loss, hemolysis, chronic disease, renal failure, marrow suppression. Renal failure produces inadequate erythropoietin (EPO) → recombinant EPO treatment. Hemolysis raises reticulocytes, raises indirect bilirubin and LDH, drops haptoglobin.
Diagnostic starting point: CBC + MCV + ferritin + reticulocyte count. Iron deficiency demands investigation of GI bleeding sources — in adult men and post-menopausal women, iron deficiency means GI bleeding until proven otherwise.
'Anemia → take iron' is one of the most dangerous oversimplifications, masking colon cancer, B12 deficiency with neural damage, renal failure, thalassemia, and other critical diagnoses.
机制 · 别构调节与血红蛋白病变
血红蛋白怎么在肺里几乎装满、到组织里很快放空, 除了协同效应, 还有几层更细的调节机制。R/T 别构: 血红蛋白其实在两种构象之间切换 —— 低氧时四条链互相拉得紧 (T 态, tense), 不容易挂氧; 一旦开始挂氧, 结构松开变成 R 态 (relaxed), 更容易挂氧。这一紧一松, 就是协同效应背后的物理机制。
Bohr 效应 (以发现者 Christian Bohr, 1904 年的名字命名): 组织代谢会产生二氧化碳、氢离子加上升温, 这些变化会把血红蛋白推向 T 态, 同样的氧浓度下反而放出更多氧; 到了肺里, 二氧化碳被排出、酸度降低, 血红蛋白又被推回 R 态, 多装氧。具体数字上: 在肺部 (PO₂ 100 mmHg), 血红蛋白几乎 100% 饱和; 到了组织 (40 mmHg), 饱和度降到约 75% —— 也就是说静息时只卸下约四分之一, 剩下那四分之三是储备。运动时局部的 Bohr 效应、升温和 2,3-BPG 叠加, 才把这份储备也调出来, 摄取率能拉到 70–80%。同一个分子, 两种环境, 自动切换。
2,3-BPG (双磷酸甘油酸) 是红血球自己糖酵解的副产物, 会稳定 T 态, 帮着多放氧。身处高海拔或慢性缺氧时, 体内 2,3-BPG 会在数小时内升高来适应; 但储血库里保存的红血球, 2,3-BPG 会慢慢流失, 所以刚输完血的那几个小时里, 供氧效率反而会打折扣。
胎儿血红蛋白 (HbF): 胎儿用的是 α₂γ₂ 组成的血红蛋白, γ 链和 2,3-BPG 结合得差, 让 HbF 的曲线整体左移, 亲和力比母体的 HbA 更高 —— 这样胎儿才能在胎盘里抢到氧气。出生后 6 月内, HbF 会逐步被 HbA 替代。
结构错一点, 后果可以很大: 镰状细胞病 (HbS) 是 β 链第 6 位氨基酸从谷氨酸变成了缬氨酸, 缺氧时血红蛋白会聚成长纤维, 把红血球拧成镰刀状, 堵住微循环并引发溶血。β-地中海贫血是 β 链产量不够, 多出来的 α 链沉淀, 红血球还没成熟就被脾脏破坏。α-地中海贫血则是 α 链产量不足, 严重程度按缺了几个 α 基因分级, 4 个全部缺失会导致胎死宫内。
生产和回收: 骨髓每秒造约 200 万个红血球, 每天约 2000 亿个, 红血球寿命 120 天, 由脾和肝的巨噬细胞负责回收, 其中约 95% 的铁会被循环利用, 每天只损失 1–2 mg。
Chapter 5
Ferritin · the storage name tag
Ferritin · the storage name tag
Ferritin is a spherical protein cage built from 24 subunits — each cage can hold about 4,500 iron atoms (as a hydrated phosphate of oxidized Fe³⁺).
It does two things: stores iron safely so it doesn't roam free and drive Fenton chemistry (•OH radicals that damage DNA, proteins, membranes); and buffers — releases on demand, recycles when excess.
Main storage sites: liver ~60% (primary depot), marrow ~25%, spleen ~10%, muscle ~5%.
Clinically, the ferritin we measure in blood is serum ferritin — a small fraction leaked from cells, correlating positively with tissue iron, the most sensitive marker of body iron status.
Reading it downward is straightforward: the lower it is, the emptier the warehouse. Reading it upward needs a second number — ferritin is also an acute-phase reactant, raised by inflammation, liver disease, and metabolic syndrome, so a high ferritin on its own does not mean iron overload. The gate that actually prompts a hemochromatosis work-up takes two markers together: transferrin saturation > 45% AND ferritin > 200 (men) / 150 (women) — the same gate used by this scene's deep page and by the overload scene. The banded table lives on this scene's reading a ferritin number page.
A frequently-overlooked insight: iron deficiency without anemia is a clinically very common subclinical state — ferritin already <30 while hemoglobin is still normal. The body is already running on 'rationing mode' — symptoms include fatigue, poor exercise tolerance, restless legs, hair thinning, declining focus — but 'normal Hb' makes doctors dismiss it. If you suspect iron deficiency, testing ferritin is much more sensitive than testing Hb.
It does two things: stores iron safely so it doesn't roam free and drive Fenton chemistry (•OH radicals that damage DNA, proteins, membranes); and buffers — releases on demand, recycles when excess.
Main storage sites: liver ~60% (primary depot), marrow ~25%, spleen ~10%, muscle ~5%.
Clinically, the ferritin we measure in blood is serum ferritin — a small fraction leaked from cells, correlating positively with tissue iron, the most sensitive marker of body iron status.
Reading it downward is straightforward: the lower it is, the emptier the warehouse. Reading it upward needs a second number — ferritin is also an acute-phase reactant, raised by inflammation, liver disease, and metabolic syndrome, so a high ferritin on its own does not mean iron overload. The gate that actually prompts a hemochromatosis work-up takes two markers together: transferrin saturation > 45% AND ferritin > 200 (men) / 150 (women) — the same gate used by this scene's deep page and by the overload scene. The banded table lives on this scene's reading a ferritin number page.
A frequently-overlooked insight: iron deficiency without anemia is a clinically very common subclinical state — ferritin already <30 while hemoglobin is still normal. The body is already running on 'rationing mode' — symptoms include fatigue, poor exercise tolerance, restless legs, hair thinning, declining focus — but 'normal Hb' makes doctors dismiss it. If you suspect iron deficiency, testing ferritin is much more sensitive than testing Hb.
Restless legs & low iron
The link between restless legs syndrome (RLS) and low iron is one of the most-missed diagnoses in clinical practice.Mechanism: dopamine synthesis requires iron (as a TH enzyme cofactor); low iron in the substantia nigra and basal ganglia disrupts nighttime dopamine signaling, presenting as the urge to move the legs and difficulty falling asleep.
Key evidence (Allen 2018, an IRLSSG task force report): RLS patients have low brain iron even when serum iron and Hb are normal.
Diagnostic marker: plasma ferritin. The target in RLS patients is ferritin > 75–100 µg/L (far above the standard lower reference of 30).
Treatment: patients with ferritin <75 typically improve significantly with oral or IV iron; supplementation has no effect once stores are replete.
RLS is common in pregnancy because iron demand spikes — third-trimester RLS incidence reaches 25%.
So for 'urge to move legs at night / trouble falling asleep / restless legs' plus ferritin <75, iron is step one — don't jump straight to dopamine agonists.
allen-2018-irlssg-iron-rls
Reading a ferritin number
A lookup page — why it reads this way is in the scene body.| Ferritin (µg/L) | Meaning |
|---|---|
| < 15 | Absolute deficiency (empty warehouse) |
| 15–30 | Low stores, borderline |
| 30–100 | Normal/adequate |
| 100–300 | Replete |
| > 300 | Elevated — think inflammation / liver disease / metabolic syndrome first; this number alone cannot establish iron overload |
| Transferrin saturation > 45% AND ferritin > 200 (men) / 150 (women) | Work up iron overload, proceed to HFE genotyping |
The last two rows are not two points on one scale — they are two different things. Isolated high ferritin is most often inflammation, not overload; moving toward hemochromatosis requires transferrin saturation as the second marker. This is the same gate used by this story's overload scene and its L4 stage — the site has exactly one.
Read the low bands against an inflammation marker too: chronic inflammation lifts ferritin, so someone with a high C-reactive protein: A liver protein that rises with inflammation — a common blood marker for 'is the body inflamed'. sitting at 30–100 may still be genuinely iron deficient. The first pair of tests for any anemia is ferritin + CRP/ESR.
zoller-2022-easl-haemochromatosis
Chapter 6
Deficiency ≠ anemia (yet)
Deficiency ≠ anemia (yet)
Iron is the world's most common micronutrient deficiency — WHO estimates ~30% of the global population is iron-insufficient.
High-risk groups:
Reproductive-age women and heavy menstruators — 30–80 mL monthly loss = 15–40 mg of ironPregnancy and lactation — demand spikes to build blood volume for fetus and infant (pregnancy RDA 27 mg vs baseline 18)Pure vegan or near-vegan diets — non-heme absorption low and lacking enhancersEndurance athletes — 'sports anemia' from sweat losses and foot-strike hemolysis (mechanical stress under the foot lyses red cells)Chronic inflammation or GI bleeding — colon cancer, hemorrhoids, aspirin abuseInfants 6–24 months — after weaning, complementary foods often under-fortified
Symptom staircase (mild to severe):
1. Fatigue, declining exercise tolerance (ferritin <30)
2. Reduced focus, foggy memory (low stores affect neurotransmitter synthesis)
3. Restless legs syndrome (RLS), legs needing to move at night
4. Hair thinning, increased shedding
5. Thin, brittle, spoon-shaped nails (koilonychia)
6. Pica (appetite distortion, craving ice, dirt, paper) — a classic signal of iron deficiency
7. Pale skin, palpitations, shortness of breath (frank anemia)
Frank anemia is the late stage — many people are chronically depleted through stages 1–5 without diagnosis.
Practical priority: high-risk groups should test annual Hb + ferritin rather than self-supplementing. 'Test before treat' is the unchangeable discipline of iron.
High-risk groups:
Reproductive-age women and heavy menstruators — 30–80 mL monthly loss = 15–40 mg of ironPregnancy and lactation — demand spikes to build blood volume for fetus and infant (pregnancy RDA 27 mg vs baseline 18)Pure vegan or near-vegan diets — non-heme absorption low and lacking enhancersEndurance athletes — 'sports anemia' from sweat losses and foot-strike hemolysis (mechanical stress under the foot lyses red cells)Chronic inflammation or GI bleeding — colon cancer, hemorrhoids, aspirin abuseInfants 6–24 months — after weaning, complementary foods often under-fortified
Symptom staircase (mild to severe):
1. Fatigue, declining exercise tolerance (ferritin <30)
2. Reduced focus, foggy memory (low stores affect neurotransmitter synthesis)
3. Restless legs syndrome (RLS), legs needing to move at night
4. Hair thinning, increased shedding
5. Thin, brittle, spoon-shaped nails (koilonychia)
6. Pica (appetite distortion, craving ice, dirt, paper) — a classic signal of iron deficiency
7. Pale skin, palpitations, shortness of breath (frank anemia)
Frank anemia is the late stage — many people are chronically depleted through stages 1–5 without diagnosis.
Practical priority: high-risk groups should test annual Hb + ferritin rather than self-supplementing. 'Test before treat' is the unchangeable discipline of iron.
Iron across the lifespan
RDA isn't a static number — iron demand varies sharply across life stages.| Stage | RDA (mg/day) | Key risk |
|---|---|---|
| Infant 0–6 mo | 0.27 (AI) | Breast milk iron low but bioavailable; preterm/formula need fortification |
| Infant 7–12 mo | 11 | Weaning foods must contain iron (meat purée, fortified rice cereal) |
| Toddler 1–3 y | 7 | Deficiency damages cognitive development — irreversible window |
| Children 4–8 y | 10 | |
| Boys 9–13 | 8 | |
| Boys 14–18 | 11 | Growth + muscle gain |
| Girls 14–18 | 15 | Sharp rise post-menarche |
| Men 19–50 | 8 | Excess is the bigger problem |
| Women 19–50 | 18 | Menstruation |
| Pregnancy | 27 | Fetus + placenta + blood volume; supplementation nearly unavoidable |
| Lactation | 9 | Menses often paused, demand drops |
| Post-menopausal women | 8 | Menses ended, same as men |
| Endurance athletes | RDA +30–70% | Foot-strike hemolysis + sweat losses |
Childhood deficiency leaves irreversible cognitive damage. The critical window of brain myelination, neurotransmitter synthesis, and hippocampal development runs from 6 months to 3 years. Deficiency during this window — even if later replenished — leaves long-lasting deficits in cognition, attention, and learning ability — infants treated for iron deficiency still scored worse on behavioral and developmental outcomes more than 10 years later (Lozoff 2000, *Pediatrics*, >10-year follow-up).
This is why WHO ranks infant iron deficiency as the top global child-nutrition issue — the consequences are far worse than the visible short-term anemia.
lozoff-iron-10yr-followup-2000lozoff-georgieff-iron-brain-2006
Chapter 7
Don't supplement blindly
Don't supplement blindly
Iron isn't like water-soluble vitamins where excess just gets excreted — the body has no active iron excretion mechanism. Daily net loss is only 1–2 mg (gut epithelial shedding + sweat + trace urine); balance is controlled by regulating absorption.
Overload risk splits into two scenarios.
Acute toxicity (child swallowing adult iron pills): counted as elemental iron, the dose falls into three bands — under 20 mg/kg is usually uneventful; 20–60 mg/kg is mild-to-moderate toxicity; over 60 mg/kg can be fatal. The band that matters most is the middle one: at or above 40 mg/kg, or with obvious and persisting symptoms, the child must be evaluated at a medical facility. Iron pills are one of the most common preventable pediatric poisonings. Presentation: severe GI bleeding + metabolic acidosis + liver failure.
Why the gap matters: a common 325 mg ferrous sulfate tablet holds about 65 mg of elemental iron. For a 12 kg toddler, 5 tablets already clear 20 mg/kg, while the 60 mg/kg line takes 11 — quoting only the highest band turns a child who already needs care into 'not there yet, let's watch'.
If ingestion is suspected, do not wait at home for symptoms — call poison control or go to the emergency department. Serious toxicity usually declares itself within 6 hours of ingestion, but that observation window belongs to medical staff, not to the kitchen table.
Chronic overload: hereditary hemochromatosis (HFE C282Y homozygous, ~1/200 in Northern European descent) breaks the hepcidin response, causing lifelong over-absorption. Iron deposits in order — liver, heart, pancreas, skin, joints — producing irreversible damage. Clinical picture: iron-overload cardiomyopathy, cirrhosis, diabetes ('bronze diabetes'), gonadal atrophy, arthritis. Treatment is the ancient but effective remedy: phlebotomy.
A few principles: men and post-menopausal women should NOT routinely take iron-containing multivitamins or single iron supplements without documented deficiency; multivitamins for men typically contain no iron — this is science, not skimping; iron supplements at home must be kept absolutely out of reach of children.
Test ferritin before supplementing — this is the unchangeable discipline of iron.
Overload risk splits into two scenarios.
Acute toxicity (child swallowing adult iron pills): counted as elemental iron, the dose falls into three bands — under 20 mg/kg is usually uneventful; 20–60 mg/kg is mild-to-moderate toxicity; over 60 mg/kg can be fatal. The band that matters most is the middle one: at or above 40 mg/kg, or with obvious and persisting symptoms, the child must be evaluated at a medical facility. Iron pills are one of the most common preventable pediatric poisonings. Presentation: severe GI bleeding + metabolic acidosis + liver failure.
Why the gap matters: a common 325 mg ferrous sulfate tablet holds about 65 mg of elemental iron. For a 12 kg toddler, 5 tablets already clear 20 mg/kg, while the 60 mg/kg line takes 11 — quoting only the highest band turns a child who already needs care into 'not there yet, let's watch'.
If ingestion is suspected, do not wait at home for symptoms — call poison control or go to the emergency department. Serious toxicity usually declares itself within 6 hours of ingestion, but that observation window belongs to medical staff, not to the kitchen table.
Chronic overload: hereditary hemochromatosis (HFE C282Y homozygous, ~1/200 in Northern European descent) breaks the hepcidin response, causing lifelong over-absorption. Iron deposits in order — liver, heart, pancreas, skin, joints — producing irreversible damage. Clinical picture: iron-overload cardiomyopathy, cirrhosis, diabetes ('bronze diabetes'), gonadal atrophy, arthritis. Treatment is the ancient but effective remedy: phlebotomy.
A few principles: men and post-menopausal women should NOT routinely take iron-containing multivitamins or single iron supplements without documented deficiency; multivitamins for men typically contain no iron — this is science, not skimping; iron supplements at home must be kept absolutely out of reach of children.
Test ferritin before supplementing — this is the unchangeable discipline of iron.
Hemochromatosis screening
Hereditary hemochromatosis (HH, HFE C282Y homozygous) is the most common autosomal recessive disease in European-descent populations.On frequency: ~1/200–300 of Northern European descent are C282Y homozygous, about 10% are heterozygous; extremely rare in Asian and African populations. Mechanism: HFE gene loss-of-function, hepcidin can't be properly upregulated, lifelong over-absorption, iron accumulates in liver, heart, pancreas, skin, joints, gonads.
Symptoms typically appear after age 40–60: fatigue, joint pain, hepatomegaly → progression to cirrhosis, cardiomyopathy, diabetes ('bronze diabetes'), gonadal atrophy, plus skin hyperpigmentation. Women, due to menstrual loss, typically present about 10 years later.
Screening: transferrin saturation >45% AND ferritin >200 (men) / 150 (women) prompts HFE genotyping; C282Y homozygous plus clinical evidence is diagnostic.
Treatment: phlebotomy is the ancient but only curative approach — start weekly until ferritin <50, then maintenance every 3–4 months. Early treatment gives normal lifespan; patients who have progressed to cirrhosis still face substantially elevated hepatocellular carcinoma risk even after treatment, and need lifelong surveillance.
If you see 'family history + new-onset arthritis + elevated ALT + diabetes, possibly with skin darkening', think iron overload — don't default to other common causes.
zoller-2022-easl-haemochromatosis
References · 6
- National Institutes of Health, Office of Dietary Supplements. (2024). Iron — Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Iron-HealthProfessional
- Hallberg, L., Brune, M., & Rossander, L. (1989). The role of vitamin C in iron absorption. International Journal for Vitamin and Nutrition Research. Supplement, 30, 103–108.
- Camaschella, C. (2015). Iron-deficiency anemia. The New England Journal of Medicine, 372(19), 1832–1843. 10.1056/NEJMra1401038
- Institute of Medicine. (2001). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academies Press. www.ncbi.nlm.nih.gov/books/NBK222310
- Ajioka, R. S., Phillips, J. D., & Kushner, J. P. (2006). Biosynthesis of heme in mammals. Biochimica et Biophysica Acta (BBA) — Molecular Cell Research, 1763(7), 723–736. 10.1016/j.bbamcr.2006.05.005
- Needleman, H. (2004). Lead poisoning. Annual Review of Medicine, 55, 209–222. 10.1146/annurev.med.55.091902.103653